Document:

<PAGE>

                              SEPARATION AGREEMENT

            This Agreement ("Separation Agreement") is dated as of November 8,
2002, and is between Neil Blechman, an individual residing at 30 Setalcott
Place, Setauket, New York 11733 ("Executive"), and Twin Laboratories Inc.
("Company"), a Utah corporation with its principal place of business at 150
Motor Parkway, Hauppauge, New York 11788.

            1. Retirement. Executive and Company are parties to an employment
agreement, dated as of January 1, 2001, attached hereto as Exhibit "A" (the
"Employment Agreement"). Capitalized terms used herein shall have the meaning
set forth in the Employment Agreement. Executive and Company agree that the
Executive has retired from the Company, effective as of the date of this
Separation Agreement (the "Retirement Date"). Except as otherwise set forth
herein, the Executive's employment, and the Employment Agreement, are terminated
as of the Retirement Date, provided, however, that Executive and Company agree
that the provisions set forth in Sections 3(d), 5, 6, 7, 10(b) and 10(k) of the
Employment Agreement, as amended herein, are valid, binding, continuing and
enforceable and shall survive the termination of the Employment Agreement.

            2. Non-Competition; Non-Solicitation. Notwithstanding anything to
the contrary set forth in this Separation Agreement or the Employment Agreement,
as amended herein, the parties agree that the period during which Executive must
observe the non-competition provisions set forth in Section 5 of the Employment
Agreement and the non-solicitation provisions set forth in Section 6 of the
Employment Agreement (the "Non-Compete Period") shall be for the three-year
period ending November 8, 2005. Provided Executive is not in breach of this
Separation Agreement, or the surviving provisions of the Employment Agreement,
as amended herein, the Non-Compete Period shall expire at the time that the
Company fails to make any payments of the Base Salary the Company is legally
obligated to make under this Separation Agreement.

            3. Severance. Provided Executive is not in breach of this Separation
Agreement, or the surviving provisions of the Employment Agreement, as amended
herein, Section 5 of the Employment Agreement is amended so that Company shall
make payments to Executive of (a) the Base Salary through the end of the
Non-Compete Period (the "Severance Period"), paid in accordance with the normal
payroll practices of the Company and (b) all unreimbursed business expenses
incurred by Executive which have been submitted to the Company (and set forth on
Exhibit B attached hereto) but not paid as of the Retirement Date, paid as soon
as practicable after the Retirement Date. If Executive dies, all amounts payable
to Executive under this Section 3 shall be paid to Executive's devisee, legatee,
or other designee or, if there is no such designee, to designee's estate.

            Benefits. Executive shall be entitled to all benefits accrued up to
the Retirement Date under all employee benefit plans of the Company, in
accordance with the terms of such plans. In addition, during the Severance
Period, provided Executive is not in breach of

<PAGE>

                                                                               2

this Separation Agreement, or the surviving provisions of the Employment
Agreement, as amended herein, the Company shall (a) arrange for Executive to
participate in and receive the Company's medical, dental, prescription drug,
insurance plans as in effect from time to time during the Severance Period on
the same terms and conditions as are provided to general employees of the
Company, provided that the medical coverage extended hereunder shall not include
the Executive Medical Plan and (b) shall reimburse Executive for the premiums
paid by Executive in respect of Executive's Universal Life Insurance Policy
(Policy No. ___) in the face amount of $250,000.

            4. Executive agrees, except as expressly set forth herein, to
surrender and forego, as of the date of this Separation Agreement, any and all
of his right to any benefits under paragraph 3(c) of the Employment Agreement,
including any car allowance. Executive and members of his immediate family shall
be provided with Company products in quantities and at times as they shall
reasonably request.

            5. No Further Liability; Mutual Release. This Separation Agreement
shall operate to fully discharge and release the Executive, his devisees,
legatees, or other designees or his estate and the Company, its directors,
officers, employees, subsidiaries, affiliates, stockholders, successors,
assigns, agents and representatives from any further obligation or liability to
the other (other than any obligations the Company may have pursuant to Company's
Stock Incentive and Stock Option Plans) with respect to, in connection with or
arising out of Executive's employment or the termination of Executive's
employment except for the obligations set forth in this Separation Agreement or
the surviving provisions of the Employment Agreement, as amended herein. The
Executive and the Company each expressly waive any and all rights to pursue any
remedy at law or in equity related to the Executive's employment or the
termination thereof. Contemporaneously with the execution and delivery of this
Separation Agreement, the Executive and the Company are executing releases in
the forms of Exhibits C and D hereto, respectively.

            6. In the event that Executive shall materially breach any of the
provisions of this Separation Agreement, in addition to any other remedies the
Company may have, the Company shall have the right to cease all benefits granted
hereunder and in the surviving provisions of the Employment Agreement, as
amended herein.

            7. Continuing Obligations. Executive agrees that he will comply with
the requirements of Sections 10(b) and 10(k) of the Employment Agreement.

            8. Announcements; Confidentiality.

                  (a) The press release with respect to the retirement of
Executive is attached as Appendix E to this Separation Agreement. The Company
agrees to consult with Executive prior to issuing any public statement with
respect to his retirement.

                  (b) Executive agrees that he will not, without the prior
written consent of the Company, disclose to any person or entity any of the
terms, conditions or

                                       2
<PAGE>
                                                                               3

other facts with respect to this Separation Agreement, except for disclosure (i)
to his legal and financial advisors and immediate family members, (ii) if
required by order of a court or other body having jurisdiction over such matter,
and (iii) with the written consent of the Company.

            9. Remedies for Breach. The parties hereto agree that Executive is
obligated under this Separation Agreement to render obligations of a special,
unique, unusual and extraordinary character, thereby giving this Separation
Agreement special and extraordinary value, and, in the event of a breach or
threatened breach of any provision of this Separation Agreement by Executive,
the injury or imminent injury to the value and the goodwill of the Company's
business could not be reasonably or adequately compensated by damages in an
action at law. Executive expressly acknowledges that the Company shall be
entitled to specific performance, injunctive relief and any other applicable
equitable remedy against Executive without the posting of a bond in the event of
any breach or threatened breach of any provision of this Separation Agreement by
Executive. Without limiting the generality of the foregoing, if Executive
breaches or threatens to breach any of the provisions of Sections 5, 6, or 7 of
the Employment Agreement, as amended herein, or Sections 8 or 9 of this
Separation Agreement, such breach or threatened breach will entitle the Company
to enjoin Executive from engaging in any activities prohibited by such
provisions. This provision shall not be construed as a waiver of any of the
rights that the Company may have for damages under this Separation Agreement or
otherwise.

            10. Reasonableness of Restrictions. Executive agrees and
acknowledges that:

                  (a) the provisions of Sections 5, 6 and 7 of the Employment
Agreement, as amended herein, may limit his ability to earn a livelihood in a
business similar to the business of the Company but nevertheless agrees that
such provisions are reasonable and necessary for the protection of the Company
and do not impose a greater restraint than is necessary to protect the goodwill
or other business interest of the Company;

                  (b) such provisions contain reasonable limitations as to the
time and the scope of activity to be restrained; and

                  (c) the consideration provided under this Separation Agreement
is sufficient to compensate Executive for the restrictions imposed in Sections
5, 6, and 7 of the Employment Agreement, as amended herein. In consideration of
the foregoing and in light of Executive's education, skills and abilities,
Executive agrees that any defenses by Executive to the strict enforcement of
such provision are hereby waived by Executive and Executive agrees that he will
not assert that such provisions are void, voidable or unenforceable.

            11. Miscellaneous.

                                       3
<PAGE>
                                       4

                  (a) Personal Guaranty. The Company shall take no action which
has the direct or indirect effect of (i) reducing the amount of any personal
guarantee of Company debt (including any release or reduction of personal
liability in respect of a letter of credit benefiting the Company) by a member
of the Blechman family, and/or (ii) otherwise making more favorable to any
guarantor the terms of any such guarantee, unless such reduction and/or change
of terms affects the guarantee of Company debt by Executive which is in effect
on the date hereof in a fashion no less favorable to him. Executive and his
spouse shall cooperate and shall take, or cause to be taken, all action
necessary in respect of that certain Reimbursement and Security Agreement No. 2,
dated as of April 9, 2001, by and among Twinlab Corporation, a Delaware
corporation, the Company, Advanced Research Press, Inc., a New York corporation,
Changes International, Inc., a Florida corporation, PR Nutrition, Inc., a
California corporation, Health Factors International, Inc., a Delaware
corporation, Bronson Laboratories, Inc., a Delaware corporation, on the one
hand, and Ross Blechman, Linda Blechman, Dean Blechman, Sharon Blechman, Brian
Blechman, Robin Blechman, Steve Blechman, Elyse Blechman, Neil Blechman and
Helena Blechman, on the other hand, and any other document or instrument related
thereto, or entered into in connection therewith, including executing all
necessary or appropriate waivers, consents, approvals, releases of liens or
other documents, to enable the Company or any of its subsidiaries to transfer,
sell or otherwise dispose of any of its assets from time to time.

                  (b) Cooperation. Executive shall cooperate with the Company,
as may be reasonably requested by the Company, to effect a transition of
Executive's responsibilities and to ensure that the Company is aware of all
matters being handled by Executive and to be available during the Non-Compete
Period to assist the Company in connection with such transition without further
compensation, provided that such assistance does not significantly interfere
with other employment of Executive. In addition to his other obligations under
this Separation Agreement, during the first twelve (12) months of the
Non-Compete Period, Executive will be available as the Company may reasonably
require for depositions, testimony and other matters relating to litigation
involving the Company.

                  (c) Counterparts; Facsimile Transmissions. This Separation
Agreement may be executed in any number of counterparts, each of which when so
executed, then delivered or transmitted by telefax, shall be deemed to be an
original and all of which taken together shall constitute but one and the same
instrument.

                  (d) Severability. If any provision of this Separation
Agreement is held invalid or unenforceable by any court of competent
jurisdiction, the other provisions of this Separation Agreement will remain in
full force and effect. Any provision of this Separation Agreement held invalid
or unenforceable only in part or degree will remain in full force and effect to
the extent not held invalid or unenforceable.

                  (e) Waivers and Amendments. This Separation Agreement may be
amended, superseded, canceled, renewed or extended, and the terms hereof may be
waived, only by written instrument signed by the Company and the Executive. No

                                       4
<PAGE>
                                                                               5

delay on the part of any party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof.

                  (f) Entire Agreement. Except as otherwise set forth herein,
this Separation Agreement (including certain provisions of the Employment
Agreement, as amended herein, and specified herein), constitutes the entire
agreement among the parties pertaining to the subject matter hereof and
supersede all prior agreements, understandings, negotiations and discussions,
whether oral or written, of the parties.

                  (g) Successors and Assigns. This Separation Agreement is
binding upon the parties and each of their respective successors, heirs and
permitted assigns.

                  (h) No Mitigation. The Executive shall not be required to
mitigate the amount of any payment provided for pursuant to this Separation
Agreement by seeking other employment and, to the extent that the Executive
obtains or undertakes other employment (including self-employment), no such
payment will be reduced by the earnings of the Executive from the other
employment.

                  (i) Costs and Expenses. The Company shall pay directly the
fees and expenses of Executive's counsel in the amount of up to $7,500 in
connection with the negotiation, execution, delivery and performance of this
Separation Agreement. If an action or proceeding is commenced by a party to
enforce or interpret any provision of this Separation Agreement, each party
shall pay its own costs and expenses of such action or proceeding, including
attorney's fees.

                  (j) Governing Law. This Agreement is governed by the laws of
the State of New York, without giving effect to principles of conflict of laws.

                  (k) Jurisdiction; Service of Process. Any action or proceeding
seeking to enforce any provision of, or based on any right arising out of, this
Agreement must be brought against any of the parties in the courts of the State
of New York, County of Suffolk, or, if it has or can acquire jurisdiction, in
the U.S. District Court for the Eastern District of New York, and each of the
parties consents to the jurisdiction of those courts (and of the appropriate
appellate courts) in any such action or proceeding and waives any objection to
venue laid therein. Process in any such action or proceeding may be served by
sending or delivering a copy of the process to the party to be served at the
address and in the manner provided for the giving of notices in Section 11(l).
Nothing in this Section 11(k), however, affects the right of any party to serve
legal process in any other manner permitted by law.

                  (l) Notices. Every notice or other communication required or
contemplated by this agreement must be in writing and sent by one of the
following methods:

                        (i) personal delivery, in which case delivery is deemed
to occur on the day of delivery;

                                       5
<PAGE>
                                                                               6

                        (ii) certified or registered mail, postage prepaid,
return receipt requested, in which case delivery is deemed to occur on the day
it is officially recorded by the U.S. Postal Service as delivered to the
intended recipient; or

                        (iii) next-day delivery to a U.S. address by recognized
overnight delivery service such as Federal Express or Airborne Express in which
case delivery is deemed to occur upon receipt. In each case, a notice or other
communication sent to a party must be directed to the address for that party set
forth below, or to another address designated by that party by written notice:

                  If to Executive to:

                                   Neil Blechman
                                   30 Setalcott Place
                                   Setauket, New York 11733

                  If to Company to:

                                   Twin Laboratories Inc.
                                   150 Motor Parkway, Suite 210
                                   Hauppauge, New York 11788
                                   Attn.: Ross Blechman, Chief Executive Officer

                  With a copy to:

                                   Twin Laboratories Inc.
                                   150 Motor Parkway, Suite 210
                                   Hauppauge, New York 11788
                                   Attn.:  General Counsel

            12. Assignment and Transfer; No Third Party Beneficiary.

                  (a) Company. This Agreement shall inure to the benefit of and
be enforceable by, and may be assigned by the Company to, any existing or future
subsidiary or affiliate of the Company (with a continuing guarantee of
performance by the Company), and shall be assigned to any purchaser of all or
substantially all of the Company's business or assets or any successor to the
Company (each, a "Successor"), whether direct or indirect, by purchase, merger,
consolidation, operation of law or otherwise. The Company will require any such
Successor by agreement in form and substance reasonably satisfactory to
Executive, to expressly assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it
if no such purchase, merger, consolidation, succession or assignment had taken
place. Regardless of whether such agreement is executed, this Agreement shall be
binding upon any Successor of the Company in accordance with the operation of
law, and such Successor shall be deemed to be the Company for purposes of this
Agreement.

                                       6
<PAGE>
                                                                               7

                  (b) Executive. Executive's rights and obligations under this
Agreement shall not be transferable by Executive by assignment or otherwise, and
any purported assignment, transfer, alienation or delegation thereof shall be
void; provided, however, that if Executive shall die, (i) all amounts payable to
Executive under Section 3 of this Separation Agreement shall be paid in
accordance with the terms of this Agreement to Executive's devisee, legatee or
other designee or, if there be no such designee, to Executive's estate, and (ii)
all benefits provided to any beneficiary or dependent of Executive under Section
4 of this Separation Agreement shall continue to be provided to such person for
the remainder of the Severance Period, if any.

            IN WITNESS THEREOF, the parties have executed this Agreement.

TWIN LABORATORIES INC.                      EXECUTIVE

By: ______________________                  By: _____________________
    Name:  Ross Blechman                        Name:  Neil Blechman
    Title: President and CEO

Date:____________________                   Date:___________________

Agreed to and Accepted:

TWINLAB CORPORATION                         Accepted and Agreed to only as
                                            to Section 11(a):

By:______________________                   By: _____________________
    Ross Blechman                               Name:  Helena Blechman
    President and CEO

Date: ___________________                   Date: ___________________

                                       7<PAGE>
                                                              EXECUTION COPY

                            ASSET PURCHASE AGREEMENT

                                  BY AND AMONG

                            BRONSON NUTRITIONALS, LLC

                                     "BUYER"

                           KABCO PHARMACEUTICALS, INC.

                           BRONSON LABORATORIES, INC.

                                    "SELLER"

                                       AND

                             TWIN LABORATORIES INC.

                                    "PARENT"

                                JANUARY 17, 2003

<PAGE>
                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                 Page
                                                                                 ----
<S>                                                                              <C>
1.    Sale and Transfer of Assets...........................................       1
      1.1   Assets..........................................................       1
      1.2   No Assumption of Liabilities....................................       1
      1.3   Closing.........................................................       2
      1.4   Purchase Price..................................................       2
      1.5   Adjustments to the Purchase Price...............................       2
      1.6   Purchase Price Allocation.......................................       2

2.    Representations and Warranties of Seller and Parent...................       2
      2.1   Organization and Good Standing..................................       2
      2.2   Authorization...................................................       3
      2.3   Acquired Assets.................................................       3
      2.4   Proprietary Rights..............................................       3
      2.5   No Conflict or Violation........................................       4
      2.6   Consents........................................................       4
      2.7   Labor and Employment Matters....................................       4
      2.8   ERISA ..........................................................       5
      2.9   Litigation......................................................       5
      2.10  Certain Contracts...............................................       5
      2.11  Compliance with Applicable Law..................................       6
      2.12  Licenses........................................................       6
      2.13  Insider Interests...............................................       7
      2.14  Customers and Suppliers.........................................       7
      2.15  Environmental Matters...........................................       7
      2.16  Brokers.........................................................       8
      2.17  Disclosure......................................................       8
3.    Representations and Warranties of Buyer...............................       8
      3.1   Organization and Corporate Authority............................       8
      3.2   Authorization...................................................       8
      3.3   No Conflict or Violation........................................       8
      3.4   Consents........................................................       9
      3.5   Approval of the January Catalog.................................       9
      3.6   Brokers.........................................................       9

4.    Certain Understandings and Agreements of the Parties..................       9
      4.1   Tax Matters.....................................................       9
      4.2   Access to Records and Files.....................................       9
      4.3   Employment......................................................      10
      4.4   WARN Act........................................................      10
      4.5   Rights in "Bronson Laboratories, Inc."..........................      10
      4.6   Expenses Related to January Catalog.............................      11
      4.7   Non-Competition and Non-Solicitation............................      11
      4.8   Inventory Bill of Sale..........................................      12
</TABLE>

                                       i
<PAGE>

<TABLE>
<S>                                                                               <C>
      4.9   Transition Services Agreement...................................      12
      4.10  Bronson Customer List...........................................      12
      4.11  Further Assurances..............................................      12

5.    Survival; Indemnification.............................................      13
      5.1   Survival........................................................      13
      5.2   Indemnification by Seller and Parent............................      13
      5.3   Indemnification by Buyer........................................      14
      5.4   Indemnification Procedure.......................................      15
      5.5   Payment.........................................................      16
      5.6   Limitations.....................................................      16

6.    Documents to be Delivered on the Date Hereof..........................      16
      6.1   Closing Documents of Seller and Parent..........................      16
      6.2   Closing Documents of Buyer......................................      17

7.    Miscellaneous.........................................................      17
      7.1   Notices.........................................................      17
      7.2   Assignability and Parties in Interest...........................      18
      7.3   Governing Law...................................................      18
      7.4   Venue...........................................................      18
      7.5   Counterparts....................................................      19
      7.6   Complete Agreement..............................................      19
      7.7   Modifications, Amendments and Waivers...........................      19
      7.8   Headings; References............................................      19
      7.9   Rules of Construction...........................................      19
      7.10  Severability....................................................      20
      7.11  Investigation...................................................      20
      7.12  Expenses of Transactions........................................      20
      7.13  Enforcement of the Agreement....................................      20
</TABLE>

                                       i
<PAGE>

EXHIBITS

A.  Form of Bill of Sale
B.  Form of Inventory Bill of Sale
C.  Form of Transition Services Agreement
D.  Form of Assignment of Trademarks

SCHEDULES

1.1(a)      Acquired Assets
1.1(b)      Excluded Assets
1.2         Assumed Liabilities
1.5         Purchase Price Allocation
2           Disclosure Schedule
2.3(a)      Liens
2.4(a)      Formulations Owned by Third Parties
2.4(b)      Trademarks
2.6         Consents
2.7(a)      Current Employees of Seller
2.7(b)      Labor and Employment Contracts
2.8         Material Litigation
2.9(a)      Seller Contracts
2.9(b)      Assigned Contracts
2.11        Non-Transferable Licenses
2.13(a)(i)  Customers
2.13(a)(ii) Suppliers
2.14        Compliance with Environmental Law
4.3         Seller Employees to be Hired by Buyer

<PAGE>

                            ASSET PURCHASE AGREEMENT

      THIS ASSET PURCHASE AGREEMENT (this "AGREEMENT") is made and entered into
as of January 17, 2003, by and among Bronson Nutritionals, LLC, a New York
limited liability company ("BUYER"), Kabco Pharmaceuticals, Inc., a New York
corporation ("KABCO"), Bronson Laboratories, Inc., a Delaware corporation
("SELLER"), and Twin Laboratories Inc., a Utah corporation and parent
corporation of Seller ("PARENT").

      A. Seller is engaged in the business of selling branded vitamins and
nutritional supplements through its direct to consumer mail-order catalogs and
via the internet through the Bronson Online website, as such business is
conducted on the date hereof (the "BUSINESS").

      B. Parent owns all of the issued and outstanding shares of capital stock
of Seller.

      C. Seller desires to sell and assign to Buyer, and Buyer desires to
purchase from Seller certain assets and rights of Seller on the terms and
conditions set forth in this Agreement.

      NOW, THEREFORE, in consideration of the foregoing premises and the mutual
representations, warranties and agreements set forth herein, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto, intending to be legally bound, agree as
follows:

1. SALE AND TRANSFER OF ASSETS.

      1.1   Assets.

            (a) Acquired Assets. On the terms and subject to the conditions set
forth in this Agreement, on the date hereof (the "CLOSING DATE"), Seller,
pursuant to a Bill of Sale in the form of Exhibit A (the "BILL OF SALE"), is
conveying, transferring, assigning, selling and delivering to Buyer, and Buyer
is acquiring, accepting and purchasing, all of Seller's right, title and
interest in the assets listed on Schedule 1.1(a) (the "ACQUIRED ASSETS").

            (b) Excluded Assets. Seller is not selling, and Buyer is not
purchasing, any of the assets of Seller listed on Schedule 1.1(b) (the "EXCLUDED
ASSETS"), all of which shall be retained by Seller.

      1.2 No Assumption of Liabilities. It is understood and agreed that, except
as set forth on Schedule 1.2, Buyer is not assuming, and will not be obligated
or liable for, any direct or indirect debts, obligations, claims or liabilities
of Seller or Parent of any nature related to the Business, the Acquired Assets
or otherwise, whether absolute, accrued, contingent, liquidated or otherwise,
and whether due or to become due, asserted or unasserted, known or unknown,
including Seller's obligations in respect of taxes, employee benefit or profit
sharing plans, or litigation to which the Seller is a party. Buyer shall not
have any liabilities or obligations by reason of this Agreement, except as
expressly provided in this Agreement. Buyer will be indemnified, pursuant to
Section 5.2, from and against any claims in respect of any debts,

                                       1
<PAGE>

obligations, claims or liabilities of Seller or Parent, except to the extent
expressly assumed hereunder.

      1.3 Closing. The closing of the sale and purchase of the Acquired Assets
(the "CLOSING") is taking place at 10:00 a.m., Eastern Standard Time, on the
date hereof, at the offices of Latham & Watkins, 885 Third Avenue, New York, New
York 10022. On the date hereof, Seller is conveying, transferring, assigning,
selling and delivering to Buyer the Acquired Assets, by delivery to Buyer of the
Bill of Sale, and Buyer is paying to Seller the Purchase Price as provided in
Section 1.4.

      1.4 Purchase Price. The consideration to be paid by Buyer for the Acquired
Assets (the "PURCHASE PRICE") is $5,000,000, which shall be paid by wire
transfer of immediately available funds to the account designated in writing by
Seller at least two business days prior to the Closing.

      1.5 Purchase Price Allocation. The Purchase Price will be allocated for
tax purposes (the "ALLOCATION") in the manner set forth on Schedule 1.5. The
Allocation will be used by the parties in preparing all applicable tax returns
and shall be binding upon the parties and upon each of their successors and
assigns, and the parties shall report the transaction herein for tax purposes in
accordance with the Allocation and shall not take any position or action
inconsistent with the Allocation.

2. REPRESENTATIONS AND WARRANTIES OF SELLER AND PARENT.

      Each representation and warranty contained in this Article 2 is qualified
by the disclosures made in the disclosure schedule attached hereto, which is
arranged in paragraphs corresponding to the numbered and lettered paragraphs in
this Article 2 (the "DISCLOSURE SCHEDULE"). This Article 2 and the Disclosure
Schedule shall be read together as an integrated provision. Seller and Parent,
jointly and severally, represent and warrant to Buyer, as of the date hereof,
that:

      2.1 Organization and Good Standing. Seller is a corporation validly
existing and in good standing under the laws of the State of Delaware, with full
corporate power and authority to carry on the Business as it is now being
conducted, and to own, lease or operate the Acquired Assets. Seller is duly
qualified to do business and is in good standing in the State of New York and
every jurisdiction in which the character of the properties owned or leased by
it or the nature of the business conducted by it makes such qualification
necessary, except where failure to be so qualified has not and could not
reasonably be expected to have a material adverse effect on the business,
operations, assets, results of operations, condition (financial or otherwise) or
prospects of the Business or the Acquired Assets or the ability of Seller to
consummate the transactions contemplated hereby (a "MATERIAL ADVERSE EFFECT").
No jurisdiction in which Seller is not qualified or licensed as a foreign
corporation has demanded or requested in writing that it qualify or become
licensed as a foreign corporation. Complete and accurate copies of the charter
documents and bylaws of Seller, with all amendments thereto to the date hereof,
have been furnished to Buyer or its representatives.

                                       2
<PAGE>

      2.2 Authorization. Seller has all requisite corporate power and authority
to enter into this Agreement and to consummate the transactions contemplated
hereby. This Agreement and all other agreements and instruments to which Seller
or Parent is a party and which are to be delivered in connection herewith
(collectively, the "TRANSACTION DOCUMENTS"), have been duly and validly approved
by the Board of Directors of Seller and by Parent, and no other corporate
proceedings on the part of Seller or Parent are necessary to approve this
Agreement and to consummate the transactions contemplated hereby and thereby.
This Agreement and the other Transaction Documents to which Seller or Parent is
a party have been duly executed and delivered by Seller and Parent, have been
effectively authorized by all necessary corporate and shareholder action and
constitute legal, valid and binding obligations of Seller and Parent.

      2.3 Acquired Assets.

            (a) Ownership. Seller is the lawful owner of or has the right and
title to use and transfer to Buyer each of the Acquired Assets. The Acquired
Assets are free and clear of all liens, mortgages, pledges, security interests,
restrictions, prior assignments, encumbrances, legal or equitable claims of
others and other claims of any kind (each a "LIEN"), except for: (i) liens for
taxes not yet payable and (ii) Liens listed on Schedule 2.3(a). The delivery to
Buyer of the Bill of Sale will vest good title to the Acquired Assets in Buyer,
free and clear of all Liens. There are no outstanding Contracts (as defined
below) of any nature obligating Seller or Parent to directly or indirectly
transfer any of the Acquired Assets or rights or interests therein to any Person
other than Buyer. For purposes of this Agreement, "PERSON" shall mean any
individual, partnership, joint venture, association, limited liability company,
corporation, trust, unincorporated organization, Governmental Authority (as
defined below), or other entity.

            (b) Condition of the Acquired Assets. All of the Acquired Assets are
in good operating condition and repair, ordinary wear and tear accepted. None of
the Acquired Assets is in need of repair or replacement other than as part of
routine maintenance in the ordinary course of business. The Acquired Assets are
sufficient to produce a catalog similar to the catalog used in the Business
during the past year and to enable the Buyer to distribute such catalog to the
customers of the Seller listed on the customer list included in the Acquired
Assets.

            (c) Ownership of Seller. Parent is the record and beneficial owner
of all of the issued and outstanding capital stock of Seller. There are no
Contracts relating to the issuance, sale or transfer of any voting or other
equity securities of Seller. For purposes of this Agreement, "CONTRACTS" means
all contracts, agreements and other instruments and understandings of any kind,
including without limitation, loan agreements, letters of credit, guarantees,
notes, leases, employee plans, and all amendments, supplements, modifications,
extensions, or renewals in respect of the foregoing.

      2.4 Proprietary Rights. Except as set forth on Schedule 2.4(a), to the
best of Seller's knowledge based upon due inquiry, Seller (i) owns and/or has
the right to use the formulations in the Bronson Products (as hereinafter
defined) (the "FORMULATIONS") or has the right to sell the Bronson Products;
(ii) owns and/or has the right to use the trade name "Bronson Laboratories";
(iii) owns the Bronson Customer Lists (as hereinafter defined); (iv) owns and/or
has the right to use the Bronson Online website; (v) owns and/or has the right
to use the trademarks listed on Schedule 2.4(b); (v) owns and/or has the right
to use the copyrights in the January Catalog (as

                                       3
<PAGE>

hereinafter defined), the Bronson Online website and the Bronson marketing
materials; and (vi) will transfer to Buyer, on the date hereof, the trademarks
listed on Schedule 2.4(b) and the Licenses listed on Schedule 2.11, to the
extent transferable. Parent is licensing to Buyer the Formulations (or the right
to use, manufacture or sell a Formulation) that Parent may possess to the extent
such Formulation is used in a Bronson Product and is set forth on Schedule
2.4(c) (the "LICENSED Products"). Except with respect to the Licensed Products,
Seller is conveying, transferring, assigning, selling and delivering to Buyer
its rights in the Formulations Seller uses in the Bronson Products, and all
proprietary rights listed in this Section 2.4, to the extent transferable by
Seller; it being expressly understood and agreed that, except as set forth in
this Section 2.4, neither Seller nor Parent is making and shall not be deemed to
make any representation or warranty concerning or relating to any Formulation,
or any part thereof. For purposes of this Agreement, "AFFILIATE" shall mean a
Person that directly, or indirectly through one or more intermediaries, controls
or is controlled by, or is under common control with, the Person specified. For
purposes of this Agreement, "BRONSON PRODUCTS" shall mean the Bronson branded
vitamins and nutritional supplements sold by Seller through the Business.

      2.5 No Conflict or Violation. The execution, delivery and performance by
Seller and Parent of this Agreement and the other Transaction Documents to be
delivered by Seller or Parent and the consummation of the transactions
contemplated hereby and thereby do not: (i) violate or conflict with any
provision of the charter documents or bylaws of Seller or Parent or any
resolution adopted by the board of directors or stockholders of Seller or
Parent; (ii) violate in any material respect any provision or requirement of any
domestic or foreign, federal, state, or local law, statute, judgment, order,
writ, injunction, decree, award, rule, or regulation of any Governmental Entity
applicable to Seller, Parent, the Business or the Acquired Assets; (iii)
violate, result in a material breach of, constitute (with due notice or lapse of
time or both) a default or cause any material obligation, penalty, premium or
right of termination to arise or accrue under any Seller Contract (as defined
below); or (iv) result in the creation or imposition of any Lien upon the
Acquired Assets. For purposes of this Agreement, "GOVERNMENTAL ENTITY" shall
mean any United States federal, state or local, or any foreign, government,
governmental, regulatory or administrative authority, agency or commission or
any court, tribunal, or judicial or arbitral body.

      2.6 Consents. Schedule 2.6 lists all consents and notices required (i) by
law, rule, regulation or order of any Governmental Entity or (ii) by the
provisions of any material contract to which Seller or Parent is a party or by
which their respective properties are bound to be obtained or given by or on
behalf of Seller or Parent in connection with the execution of this Agreement
and the other Transaction Documents and the consummation of the transactions
contemplated hereby and thereby. All such consents have been duly obtained and
are in full force and effect and all such notices have been given.

      2.7 Labor and Employment Matters. Schedule 2.7(a) lists all current
employees of Seller, including the current title and current compensation of
such employees. Except as set forth on Schedule 2.7(b), there is no employment
agreement, severance agreement, collective bargaining agreement or other labor
or employment contract to which Seller is a party or by which it is bound. No
petition has been filed by any employee or group of employees of Seller with any
labor relations board seeking recognition of a bargaining representative for
such employees. Seller has complied in all material respects with all applicable
laws, rules and

                                       4
<PAGE>

regulations relating to employment and termination of employment of employees,
including without limitation those related to wages, hours, collective
bargaining and the payment and withholding of taxes and other sums as required
by appropriate Governmental Entities and has withheld and paid to the
appropriate Governmental Entities or is holding for payment not yet due to such
Governmental Entities, all amounts required to be withheld from employees of
Seller and is not liable for any arrears of wages, taxes, penalties or other
sums for failure to comply with any of the foregoing. There is no unfair labor
practice complaint against Seller pending, or to the knowledge of Seller or
Parent threatened, before the National Labor Relations Board or any other
Governmental Entity; there is no pending, or to the knowledge of Seller or
Parent threatened, labor strike or other material labor trouble affecting
Seller; there is no material labor grievance pending, or to the knowledge of
Seller or Parent threatened, against Seller; or pending, or to the knowledge of
Seller or Parent threatened, representation question respecting the employees of
Seller.

      2.8 ERISA. To the knowledge of Seller and Parent, except as set forth on
Schedule 2.8, no claims have been filed with any Governmental Entity by any
employee listed on Schedule 4.3(b) alleging the breach of a fiduciary obligation
by Seller or Parent prior to the date hereof under any employee benefit plan
maintained by Seller.

      2.9 Litigation. Except as set forth on Schedule 2.9, there are no claims,
actions, suits or proceedings of any nature pending or, to the knowledge of
Seller or Parent threatened, by or against Parent, Seller, the officers,
directors, employees, agents of Seller, or any of their respective Affiliates
involving, affecting or relating to the Acquired Assets or the transactions
contemplated by this Agreement. No Acquired Asset is subject to any order, writ,
judgment, award, injunction or decree of any Governmental Entity.

      2.10 Certain Contracts.

            (a) Schedule 2.10(a) lists all material Contracts to which Seller is
a party relating to, binding on or affecting any of the Acquired Assets,
including, without limitation, all: (i) supply, distribution or other Contracts
pursuant to which third parties are or will be entitled or obligated to purchase
or use any of the Acquired Assets; (ii) personal property leases or any
subleases relating thereto; (iii) Contracts limiting or restraining any of
Seller's employees from engaging or competing in any lines of business with any
Person; and (iv) other Contracts affecting the ownership of, title to, use of or
any leasehold or other interest in the Acquired Assets (each a "SELLER
CONTRACT," and collectively, the "SELLER CONTRACTS.") Schedule 2.10(b) lists all
Seller Contracts to be assumed by Buyer upon the Closing (the "ASSIGNED
CONTRACTS").

            (b) Each Seller Contract is valid, binding and enforceable against
the Seller in accordance with its terms, except as such enforceability may be
limited by general principles of equity and bankruptcy, insolvency,
reorganization and moratorium and other laws relating to creditors' rights, and
is in full force and effect. Seller has performed all material obligations
required to be performed by it under, and is not in material breach or in
default of, any Seller Contract, and no event has occurred which, with due
notice or lapse of time or both, would constitute such a material breach or
default.

                                       5
<PAGE>

             (c) To the knowledge of Seller or Parent, without any independent
investigation, no other party to any Seller Contract is in material breach or in
default in respect thereof, and no event has occurred which, with due notice or
lapse of time or both, would constitute such a material breach or default.

            (d) There are no material disputes with any party to any Seller
Contract, and to the knowledge of Seller or Parent, no party to any Seller
Contract has credibly threatened to cancel or terminate any Seller Contract,
whether as a result of the transactions contemplated by this Agreement or
otherwise.

            (e) To the knowledge of Seller or Parent, without any independent
investigation, no party to any Seller Contract has assigned any of its rights or
delegated any of its duties under such Seller Contract.

            (f) Neither the execution and delivery by Seller of this Agreement,
nor the consummation by Seller of the transactions contemplated herein in
accordance with the terms hereof, in any material respect, violates, or
conflicts with, or results in a breach of any provision of, or constitutes a
material default (or an event which, with notice or lapse of time or both, would
constitute a default) under, or results in the termination or in a right of
termination or cancellation of, or accelerates the performance required by, or
results in the triggering of any payment obligations under, or results in the
creation of any Lien upon any of the Acquired Assets under, or results in being
declared void, voidable, or without further binding effect, any of the terms,
conditions or provisions of any Seller Contract.

            (g) Seller has delivered to Buyer or its representatives true and
complete originals or copies of all the Seller Contracts and a copy of every
Material Notice received by Seller or Parent since January 1, 2001 with respect
to any of the Seller Contracts. For purposes hereof, "MATERIAL NOTICE" means
those notices alleging a breach of a Seller Contract or intention to terminate
or materially modify a Seller Contract, but does not include routine
correspondence.

      2.11 Compliance with Applicable Law. The operations of Seller are being
conducted in all material respects in accordance with all applicable laws,
regulations, orders and other requirements of all Governmental Entities having
jurisdiction over it and its assets, properties and operations, including,
without limitation, all such laws, regulations, orders and requirements relating
to the Acquired Assets. Without limiting the foregoing, Seller has complied with
all orders, judgments and decrees of any Governmental Entity under the
Occupational Safety and Health Act and its state law equivalents that apply to
the Acquired Assets, except where failure to so comply would not have a Material
Adverse Effect. Seller has not received any notice of any actual, alleged,
possible or potential material violation of any such law, regulation, order or
other legal requirement from any Governmental Authority, and to Seller's
knowledge no event has occurred nor any circumstance exists that (with or
without notice or lapse of time) may constitute or result in a violation by
Seller of, or a failure on the part of Seller to comply with, any such law,
regulation, order or other legal requirement or may give rise to any obligation
on the part of Seller to undertake or bear all or any portion of the cost of any
remedial action of any nature.

      2.12  Licenses.

                                       6
<PAGE>

            (a) Schedule 2.12 lists each material license, permit, certificate,
franchise, authorization, or approval issued or granted by any Governmental
Entity that relates to the Acquired Assets (each a "LICENSE," and collectively,
"LICENSES"). Seller has all Licenses necessary to carry on its business as
presently conducted, except where the failure to have such License would not
have a material adverse effect on the Business. Seller has delivered to Buyer or
its representatives true and complete copies of all the Licenses together with
all amendments and modifications thereto. Schedule 2.12 identifies all Licenses
that are not transferable to Buyer hereunder.

            (b) Each License has been issued to, and duly obtained and fully
paid for by Seller and is valid, in full force and effect and not subject to any
pending or, to the knowledge of Seller or Parent, threatened administrative or
judicial proceeding to suspend, revoke, cancel or declare such License invalid
in any respect. Seller is not in violation in any material respect of any of the
Licenses.

      2.13 Insider Interests. No officer, director or stockholder of Seller, or
any Affiliate of any such Person, or to the knowledge of Seller or Parent, any
family member of such individual persons, has either directly or indirectly any
rights in or to any of the Acquired Assets.

      2.14 Customers and Suppliers. Schedule 2.14(a)(i) sets forth the number of
(i) customers who have placed orders with the Seller from January 1, 2002 to
December 31, 2002, and (ii) other customers listed on the Bronson customer list
as of December 31, 2002. Schedule 2.14(a)(ii) includes the five largest
suppliers of Seller during the nine months ended September 30, 2002.

      2.15  Environmental Matters.

            Notwithstanding anything to the contrary contained in this Agreement
and except as set forth on Schedule 2.15:

            (a) Seller's ownership and operation of the Acquired Assets complies
in all material respects with all applicable laws, regulations and other
requirements of Governmental Entities or duties under common law relating to
toxic or hazardous substances, wastes, pollution or to the protection of health,
safety or the environment (collectively, "ENVIRONMENTAL LAWS") and Seller has
obtained and maintained in effect all licenses, permits and other authorizations
or registrations relating to the Acquired Assets and the Facility required under
all Environmental Laws (collectively "ENVIRONMENTAL PERMITS") and is in material
compliance with all such Environmental Permits.

            (b) Seller has not performed, failed to perform or suffered any act
relating to the Acquired Assets which could reasonably be expected to give rise
to, or has otherwise incurred, material liability relating to the Acquired
Assets to any Person (governmental or not) under the Comprehensive Environmental
Response, Compensation and Liability Act, 42 U.S.C. Section 9601 et seq.
("CERCLA"), or any other Environmental Laws, nor has it received notice of any
such liability or any claim therefore.

                                       7
<PAGE>

            (c) Seller's ownership and operation of the Acquired Assets has not
exposed any employee or third party to any Hazardous Materials or conditions
that could subject it to any material liability under any Environmental Laws.

      2.16 Brokers. No broker, finder, investment banker, or other Person is
entitled to any brokerage, finder's or other fee or commission in connection
with the transactions contemplated by this Agreement, based upon arrangements
made by or on behalf of Seller or Parent.

      2.17 Disclosure. No representation or warranty by the Seller in this
Agreement contains any untrue statement of a material fact or omits to state any
material fact necessary to make the statements in such representation or
warranty not misleading.

3. REPRESENTATIONS AND WARRANTIES OF BUYER.

      Buyer represents and warrants to Seller and Parent, as of the date hereof
and as of the Closing, that:

      3.1 Organization and Corporate Authority. Buyer is a corporation validly
existing and in good standing under the laws of the State of New York, with full
corporate power and authority to carry on its business as it is now being
conducted and to own, lease or operate the Acquired Assets. Buyer is duly
qualified to do business and is in good standing in every jurisdiction in which
the character of the properties owned or leased by it or the nature of the
business conducted by it makes such qualification necessary, except where
failure to be so qualified has not and could not reasonably be expected to have
a Material Adverse Effect on the business, operations, assets, results of
operations, condition (financial or otherwise) or prospects of its business. No
jurisdiction in which Buyer is not qualified or licensed as a foreign
corporation has demanded or requested that it qualify or become licensed as a
foreign corporation.

      3.2 Authorization. Buyer has all requisite corporate power and authority
to enter into this Agreement and to consummate the transactions contemplated
hereby. This Agreement and the other Transaction Documents to which Buyer is a
party have been duly and validly approved by the Board of Directors of Buyer and
no other proceedings on the part of Buyer are necessary to approve this
Agreement and to consummate the transactions contemplated hereby and thereby.
This Agreement and the other Transaction Documents to which the Buyer is a party
have been (or upon execution by Buyer will have been) duly executed and
delivered by Buyer, have been effectively authorized by all necessary action of
Buyer, corporate or otherwise, and constitute (or upon execution will
constitute) legal, valid and binding obligations of Buyer.

      3.3 No Conflict or Violation. The execution, delivery and performance by
Buyer of this Agreement and the other Transaction Documents to be executed and
delivered by Buyer and the consummation of the transactions contemplated hereby
and thereby do not and will not: (i) violate or conflict with any provision of
the charter documents or bylaws of Buyer; or (ii) violate in any material
respect any provision or requirement of any domestic or foreign, national, state
or local law, statute, judgment, order, writ, injunction, decree, award, rule,
or regulation of any Governmental Entity applicable to Buyer.

                                       8
<PAGE>

      3.4 Consents. No consents or notices are required to be obtained or given
by or on behalf of Buyer in connection with the execution of this Agreement and
the other Transaction Documents and the consummation of the transactions
contemplated hereby and thereby.

      3.5 Approval of January Catalog. Buyer received from Seller one copy of
the January catalog relating to the sale of the Bronson Products (the "JANUARY
CATALOG") and has approved the final form of the January Catalog, which was
printed and distributed to customers of Seller in December 2002.

      3.6 Brokers. No broker, finder, investment banker, or other Person is
entitled to any brokerage, finder's or other fee or commission in connection
with the transactions contemplated by this Agreement, based upon arrangements
made by or on behalf of Buyer.

4. CERTAIN UNDERSTANDINGS AND AGREEMENTS OF THE PARTIES.

      4.1   Tax Matters.

            (a) Seller and Buyer will each provide the other party with such
assistance as may reasonably be requested in connection with preparation of any
tax return, audit or other examination by any taxing authority or judicial or
administrative proceeding relating to liability for taxes related to or
attributable to the Acquired Assets (each, a "TAX RETURN", and collectively the
"TAX RETURNS"), will each retain and provide to the other party all records and
other information that may be relevant to any such Tax Return, audit or
examination, proceeding or determination and will each provide the other party
with any final determination of any such audit or examination, proceeding or
determination that affects any amount required to be shown on any such Tax
Return of the other party for any period. Without limiting the generality of the
foregoing, each of Buyer and Seller will retain, until the expiration of the
applicable statutes of limitation (including any extensions thereof) copies of
all such Tax Returns, supporting work schedules and other records relating to
tax periods or portions thereof ending on or prior to the Closing Date.

            (b) Notwithstanding any other provision of this Agreement, the
covenants set forth in this Section 4.1 shall survive until the expiration of
the respective statute of limitations applicable to the periods to which the
taxes referred to herein relate.

      4.2   Access to Records and Files.

            (a) Seller shall have the right for a period of five years following
the Closing Date to have reasonable access to such books, records and accounts,
correspondence, employment records and other similar information as are
transferred to Buyer pursuant to the terms of this Agreement for any lawful and
proper purpose. Buyer shall have the right for a period of five years following
the Closing Date to have reasonable access to those books, records and accounts,
correspondence, and other records which are retained by Seller pursuant to the
terms of this Agreement to the extent that any of the foregoing relate to the
Acquired Assets or to the extent that such access is required for any lawful and
proper purpose.

            (b) Buyer agrees that, in the event Seller receives written notice
of a claim relating to the Acquired Assets or any product manufactured or
distributed by Seller prior to the '

                                       9
<PAGE>

Closing Date, Buyer shall cooperate with Seller in all reasonable respects, at
Seller's cost, in the investigation, trial, defense and any appeal arising from
the matter from which such claim arose, including without limitation providing
Seller access to all information necessary for Seller's defense of such claim.

      4.3 Employment.

            (a) Except as set forth herein, Buyer shall not assume any
liabilities or obligations of Seller to any current or former employee of
Seller. Except as set forth in Section 4.3(b), Buyer shall not have any
liability or obligation to or in respect of any employee of Seller, including,
without limitation, any liability or obligation (i) to employ or engage any such
employee, (ii) arising from such employee's dismissal by Seller, whether or not
in connection with the transactions contemplated hereby, or any notice or
payment in lieu of notice required by applicable law in connection with such
dismissal, or (iii) in respect of any compensation (including severance payments
and accrued vacation or sick day payments), tenure, seniority, benefit or
welfare plan or arrangement of any kind.

            (b) Buyer agrees to offer employment or engagement to each of the
employees of Seller listed on Schedule 4.3. Except as otherwise specifically set
forth herein, the salaries, wages or compensation rates, medical insurance and
other benefits, and seniority and title of such employees shall be determined in
the sole discretion of Buyer. Notwithstanding the foregoing, Buyer agrees to
offer medical insurance to the employees of Seller hired by Buyer as soon as
permitted by its current insurance carrier that provides such plans to Buyer's
employees. At any time after the Closing, Buyer may offer employment or similar
engagements to any other former employee of Seller, notwithstanding the fact
that they were not offered employment as of the Closing Date. Seller shall have
no responsibility for any liabilities or obligations (except for any continuing
obligations of Seller required by law) with respect to any transferred
employee's employment by Buyer.

            (c) Buyer shall be obligated to comply with all applicable laws,
regulations and obligations under the Consolidated Omnibus Reconciliation Act of
1985, as amended, and any similar state law ("COBRA") for all employees of
Seller, and their respective spouses and eligible beneficiaries, hired by Buyer
on or after the date hereof.

      4.4 WARN Act. Prior to the Closing Date, Seller shall have full
responsibility for providing any notice to its employees and appropriate
government officials which may be required pursuant to the Worker Adjustment and
Retraining Notification Act of 1988, as amended (the "WARN ACT"), or any similar
state law with respect to any employees terminated by Seller. Seller will bear
any costs, obligations or liabilities which may accrue, prior to the Closing
Date, to such employees or any unit of local government under such Act or any
similar state law as a result of improper or untimely notice or other failure to
comply with such laws. Seller shall have no responsibility under the WARN Act
with respect to any employees of Seller employed by Buyer after the Closing
Date.

      4.5 Rights in "Bronson Laboratories, Inc.". Promptly after the Closing
Date, Seller will, and Parent will cause Seller to, change its name to Twinlab
Catalog Corp., or such other name not confusingly similar with "Bronson
Laboratories, Inc.", which does not contain the

                                       10
<PAGE>

word "Bronson", as may be acceptable to Buyer. From and after the Closing Date,
neither Parent, Seller nor any of their Affiliates will employ the term
"Bronson" or "Bronson Laboratories" or a confusingly similar term in its
business, except in connection with documents referencing the fact that Seller
was previously a wholly owned subsidiary of Parent. From and after the Closing
Date, Seller shall provide Buyer all documents of assignment reasonably
requested by Buyer to transfer to Buyer all of Seller's right, title and
interest in the name "Bronson Laboratories."

      4.6 Expenses Related to January Catalog. Buyer shall have full
responsibility for the payment of all fees, costs and expenses relating to the
printing and production of the January Catalog. Buyer and Seller agree that
Seller shall be responsible for the payment of the postage fees of mailing the
January Catalog (the "POSTAGE FEES"), only to the extent such Postage Fees are
equal to or less than $30,000. Buyer agrees that it shall reimburse Seller for
any Postage Fees in excess of $30,000, which amount, if any, is being paid on
the date hereof.

      4.7 Non-Competition and Non-Solicitation.

            (a)   Non-Competition

                  (i) Until the date that is thirty (30) months after the
Closing Date, Seller and Parent shall not, directly or indirectly, on their
behalf or on behalf of others, own, manage, operate, control or participate in
the ownership, management, operation or control of, or provide consulting
services to, any other corporation, firm, business, partnership, person,
proprietorship or other entity engaged in or carrying on the Business (other
than the business of selling branded vitamins and nutritional supplements via
the internet channel of distribution, which is governed exclusively by the
provisions of clause (ii) hereof).

                  (ii) Until the date that is one year after the Closing Date,
Seller and Parent shall not, directly or indirectly, on their behalf or on
behalf of others, own, manage, operate, control or participate in the ownership,
management, operation or control of, or provide consulting services to, any
other corporation, firm, business, partnership, person, proprietorship or other
entity engaged in or carrying on the business of selling branded vitamins and
nutritional supplements (other than any branded products currently sold by
Parent or any successor in interest of Parent) via the internet channel of
distribution.

                  (iii) The provisions of clause (i) of this Section 4.7(a)
shall terminate on or as of the date that is six months after the Closing Date
in the event of the sale, merger, consolidation, disposition or sale of all or
substantially all of the assets of Parent to, with or into any other Person.
However, at no time subsequent to the date hereof shall Seller or Parent or any
successor in interest of Seller or Parent, directly or indirectly, use the name
"Bronson" or any Bronson Customer List (as defined below) in connection with the
business activities of Seller or Parent, except as provided for herein.

            (b) Until the first anniversary of the Closing Date, Seller and
Parent shall not, and shall cause their Affiliates not to, directly or
indirectly, on their behalf or on behalf of others, hire or attempt to hire, or
cause any other Person to hire or attempt to hire, any employee of Buyer
(including without limitation persons employed or engaged by Seller before the
Closing

                                       11
<PAGE>

Date who accept offers of employment with Buyer), or directly or
indirectly entice or solicit or seek to induce or influence any of such
employees to leave their employment or engagement with Buyer.

            (c) Except for the employees listed on Schedule 4.3, until the first
anniversary of the Closing Date, Buyer shall not, and shall cause its Affiliates
not to, directly or indirectly, on its behalf or on behalf of others, hire or
attempt to hire, or cause any other Person to hire or attempt to hire, any
employee of Parent or its Affiliates, or directly or indirectly entice or
solicit or seek to induce or influence any of such employees to leave their
employment or engagement with Parent or its Affiliates.

            (d) The covenants set forth in subsections (a), (b) and (c) above
shall be read and interpreted with every reasonable inference given to their
enforceability. However, if any term, provision or condition of such covenants
is held by a court or arbitrator to be invalid, void or unenforceable, the
remainder of the provisions thereof shall remain in full force and effect and
shall in no way be affected, impaired or invalidated. If a court or arbitrator
should determine any of such covenants are unenforceable because of
over-breadth, then the court or arbitrator shall modify such covenant so as to
make it enforceable to the fullest extent the court or arbitrator deems
reasonable and enforceable under the prevailing circumstances.

      4.8 Inventory Bill of Sale. As of the date hereof and as a condition to
the purchase of the Acquired Assets, Seller shall have sold and Buyer shall have
purchased certain inventory of the Seller pursuant to a bill of sale (the
"INVENTORY BILL OF SALE") in the form of Exhibit B.

      4.9 Transition Services Agreement. As of the date hereof, Buyer and Seller
shall enter into a Transition Services Agreement, in the form of Exhibit C,
setting forth the terms by which Seller will assist Buyer in the continuance of
the Business for a period of time sufficient to allow Buyer to relocate the
Acquired Assets to the Buyer's New York facility.

      4.10 Bronson Customer List. Seller and Parent agree that, subsequent to
the Closing Date, they shall not use, maintain, copy or distribute, or permit
any Affiliate, officer or director of Seller or Parent to use maintain, copy or
distribute, for any purpose relating to the Business or otherwise, any customer
list of Seller being sold to Buyer pursuant to this Agreement (each, a "Bronson
Customer List"). Seller and Parent agree that, subsequent to the date hereof,
they shall not maintain any copies of any Bronson Customer List, in any form
whatsoever, except to the extent necessary to perform their obligations under
the Transition Services Agreement, or as required by law.

      4.11 Further Assurances. Upon the reasonable request of a party or parties
hereto at any time after the Closing Date, the other party or parties shall
forthwith execute and deliver such further instruments of assignment, transfer,
conveyance, endorsement, direction or authorization and other documents as the
requesting party or parties or its or their counsel may reasonably request in
order to perfect title of Buyer and its successors and assigns to the Acquired
Assets or otherwise to effectuate the purposes of this Agreement (including with
respect to the Formulations). Each party agrees to use all reasonable efforts
and to exercise good faith in fulfilling its obligations under this Agreement.

                                       12
<PAGE>

      4.12 Obligations of Buyer. Kabco shall cause Buyer to perform all of the
obligations of Buyer under this Agreement.

5. SURVIVAL; INDEMNIFICATION.

      5.1 Survival. The representations and warranties made in this Agreement or
any other Transaction Document shall survive any investigation made by any party
hereto and the Closing of the transactions contemplated hereby until the first
anniversary of the Closing Date, except those representations and warranties
contained in (i) Section 2.16 (Brokers), which will survive until the expiration
(including extensions) of the applicable statute of limitations; and (ii)
Section 2.3 (Acquired Assets), which will survive indefinitely. No party will be
liable to another under any warranty or representation contained herein after
the applicable expiration of such warranty or representation; provided however,
if a claim or notice is given under this Article 5 with respect to any
representation or warranty in reasonable detail prior to the applicable
expiration date, such claim may be pursued to resolution notwithstanding
expiration of the representation or warranty under which the claim was brought.
Completion of the transactions contemplated hereby shall not be deemed or
construed to be a waiver of any right or remedy of any of the parties.

      5.2 Indemnification by Seller and Parent. Subject to the limits set forth
in this Article 5, Seller, Parent and their successors and assigns shall,
jointly and severally, indemnify, defend, reimburse and hold harmless Buyer and
its Affiliates and their successors and assigns, and the officers, directors,
employees and agents of each of them, from and against any and all claims,
losses, damages, liabilities, obligations, assessments, penalties and interest,
demands, actions and expenses, whether direct or indirect (including, without
limitation, settlement costs, legal and accounting fees and expenses and any
other expenses for investigating or defending any actions or threatened actions)
("LOSSES") reasonably incurred by any such indemnitee, arising out of or in
connection with any of the following:

            (a) The ownership by Parent and Seller of the Excluded Assets, at
any time, before or after the Closing Date, including without limitation with
respect to any product manufactured, marketed or distributed in whole or in part
by Parent or Seller;

            (b) the ownership or operation of the Acquired Assets before the
Closing Date;

             (c) any untruth or inaccuracy of any representation or warranty
made by Seller or Parent in this Agreement or any other Transaction Document;

            (d) any breach of any covenant, agreement or obligation of Seller or
Parent contained in this Agreement or any other Transaction Document;

            (e) any failure to comply with applicable bulk sales laws or
fraudulent transfer laws in connection with the transactions contemplated
hereby;

            (f) any liability under the WARN Act or similar state or local law
caused by any action of Seller prior to the Closing Date, and any liability or
obligation to any employee of

                                       13
<PAGE>

Seller, incurred prior to the Closing Date, arising in connection with Seller's
employment or the termination of such employment;

            (g) any product liability claims against Buyer relating to the
manufacture, ownership, sale and/or operation of the Acquired Assets prior to
the Closing Date;

            (h) all taxes due or payable by Seller for periods (or portions
thereof) ending prior or subsequent to the Closing Date, except to the extent
assumed by Buyer;

            (i) the actual amount of any refunds for products sold by Seller
prior to the date hereof and returned by customers of Seller.

            (j) any claims against, or liabilities or obligations of, Seller not
specifically assumed by Buyer pursuant to this Agreement.

      5.3 Indemnification by Buyer and Kabco. Subject to the limits set forth in
this Article 5, Buyer and Kabco, and their respective successors and assigns
shall, jointly and severally, indemnify, defend, reimburse and hold harmless
Seller, Parent and their successors and assigns and their officers, directors,
employees and agents from and against any and all Losses reasonably incurred by
any such indemnitee arising out of or in connection with any of the following:

            (a) the ownership and operation of the Acquired Assets after the
Closing Date, including without limitation with respect to any product
manufactured, marketed or distributed in whole or in part by Buyer, except to
the extent that such Loss is due to the breach by the Seller of a representation
or warranty made in this Agreement or the Inventory Bill of Sale;

            (b) any untruth or inaccuracy of any representation, warranty or
certification made by Buyer in this Agreement or any other Transaction Document;

            (c) any breach of any covenant, agreement or obligation of Buyer
contained in this Agreement or any other Transaction Document;

            (d) any claims made by employees of Seller hired by Buyer on or
after the Closing Date with respect to employment obligations arising subsequent
to the Closing Date;

             (e) any liability under the WARN Act or similar state or local law
caused by any action of Buyer on or after the Closing Date, and any liability or
obligation to any employee of Buyer, incurred on or after the Closing Date,
arising in connection with Buyer's employment or termination of such employment;

            (f) any claims against, or liabilities or obligations of, Seller
assumed by Buyer pursuant to this Agreement.

                                       14
<PAGE>

      5.4   Indemnification Procedure.

            (a) Notice. Whenever any claim shall arise for indemnification
hereunder (a "CLAIM"), the party entitled to indemnification (the "INDEMNITEE")
shall promptly give written notice to the party obligated to provide indemnity
(the "INDEMNITOR") with respect to the Claim after the receipt by the Indemnitee
of reliable information of the facts constituting the basis for the Claim; but
the failure to timely give such notice shall not relieve the Indemnitor from any
obligation under this Agreement, except to the extent, if any, that the
Indemnitor is materially prejudiced thereby.

            (b) Third-Party Claims.

                  (i) Upon receipt of written notice from the Indemnitee of a
            Claim, the Indemnitor shall promptly pay the amount of the Claim,
            unless the Indemnitor shall dispute the Claim or the amount thereof,
            and the Indemnitor may provide counsel (such counsel subject to the
            reasonable approval of the Indemnitee) to defend the Indemnitee
            against the matter from which the Claim arose, at the Indemnitor's
            sole cost, risk and expense. If the Indemnitor assumes such defense,
            the Indemnitee shall cooperate in all reasonable respects, at the
            Indemnitor's sole cost, risk and expense, with the Indemnitor in the
            investigation, trial, defense and any appeal arising from the matter
            from which the Claim arose; provided, however, that the Indemnitee
            may (but shall not be obligated to) participate in any such
            investigation, trial, defense and any appeal arising in connection
            with the Claim at the sole cost of the Indemnitee. After notice from
            the Indemnitor to the Indemnitee of the Indemnitor's election to
            assume the defense, compromise or settlement of such Claim, the
            Indemnitor shall not, as long as it diligently conducts such
            defense, be liable to the Indemnitee for any fees of other counsel
            or any other expenses with respect to the defense of such Claim, in
            each case subsequently incurred by the Indemnitee in connection with
            the defense, compromise, or settlement of the Claim. The Indemnitor
            shall have the right to elect to settle any Claim for monetary
            damages without the Indemnitee's consent, only if the settlement
            includes a complete release of the Indemnitee. If the settlement
            does not include such a release, it will be subject to the consent
            of the Indemnitee, which consent shall not be unreasonably withheld.
            The Indemnitor may not admit any liability of the Indemnitee or
            waive any of the Indemnitee's rights without the Indemnitee's prior
            written consent, which consent shall not be unreasonably withheld.
            If the subject of any Claim results in a judgment or settlement, the
            Indemnitor shall promptly pay such judgment or settlement.

                   (ii) If the Indemnitor fails to promptly assume the defense
            of the subject of any Claim in accordance with the terms of Section
            5.4(b)(i), or fails diligently to prosecute such defense, the
            Indemnitee may defend against the subject of the Claim, and the
            Indemnitor shall be responsible for the reasonable expenses incurred
            by the Indemnitee in connection with such defense, including
            employment of one counsel reasonably satisfactory to the Indemnitee.
            If the Indemnitee defends the subject of a Claim in accordance with
            this Section, the Indemnitor shall cooperate with the Indemnitee and
            its counsel, at the

                                       15
<PAGE>

            Indemnitor's sole expense, in all reasonable respects, and shall
            deliver to the Indemnitee or its counsel copies of all pleadings and
            other information within the Indemnitor's knowledge or possession
            reasonably requested by the Indemnitee or its counsel that are
            relevant to the defense of the subject of any such Claim and that
            will not prejudice the Indemnitor's position, claims or defenses.
            The Indemnitee shall maintain confidentiality with respect to all
            such information consistent with the conduct of a defense hereunder.

      5.5 Payment. All payments owing under this Article 5 will be made promptly
as indemnifiable Losses are incurred.

      5.6 Limitations. Notwithstanding any provision of this Agreement to the
contrary, no party shall have any obligation to indemnify any Person entitled to
indemnity under Section 5.2(c) or 5.3(b) until and only to the extent the
aggregate Claims against the Person brought subsequent to the date that is
ninety days after the Transition Period (as defined in the Transition Services
Agreement) so entitled to indemnity shall have equaled or exceeded $40,000 (the
"THRESHOLD")(it being understood that the Threshold shall not apply to any Claim
brought during the Transition Period or within ninety days after the Transition
Period), except that claims arising from any breach of the representations and
warranties contained in Sections 2.3 (Acquired Assets), 2.16 (Brokers) and 3.6
(Brokers) shall not be subject to the Threshold.

6. DOCUMENTS TO BE DELIVERED ON THE DATE HEREOF.

      6.1 Closing Documents of Seller and Parent. Buyer shall have received, or
is receiving on the date hereof, all of the following, each duly executed by the
parties thereto (other than Buyer) and dated as of the date hereof, in form and
substance satisfactory to Buyer:

            (a) copies, certified by the Secretary or an Assistant Secretary of
      Seller or Parent, as applicable, of resolutions of its Board of Directors
      authorizing the execution, delivery and performance of this Agreement and
      the other Transaction Documents to which Seller or Parent is a party and
      the consummation of the transactions contemplated hereby and thereby;

            (b) the Bill of Sale, in the form attached hereto as Exhibit A;

            (c) the Inventory Bill of Sale, in the form attached hereto as
      Exhibit B;

             (d) the Transition Services Agreement between Buyer and Seller, in
      the form attached hereto as Exhibit C;

            (e) the Assignment of Trademarks, in the form attached hereto as
      Exhibit D;

            (f) the Formulations being sold by Seller pursuant to Section 2.4;

            (g) the Bronson Customer Lists and all customer information
      presently residing on the SIGMA computer system maintained by Seller;

                                       16
<PAGE>

            (h) the release by CIT Group/Business Credit, Inc. of all liens,
      claims and encumbrances with respect to the Acquired Assets and the
      inventory to be sold to Buyer pursuant to the Inventory Bill of Sale;

            (i) consent of certain members of the Blechman family to the release
      of all liens, claims and encumbrances with respect to the Acquired Assets
      and the inventory to be sold to Buyer pursuant to the Inventory Bill of
      Sale;

            (j) copies, certified by the Secretary or an Assistant Secretary of
      Seller, of the Certificate of Incorporation and Bylaws of Seller and the
      Bylaws of Parent;

            (k) certificates of (i) the Secretary of State of the States of
      Delaware, New York and Utah certifying as of a recent date the good
      standing of Seller in Delaware, New York and Utah, and (ii) the Secretary
      of State of the States of New York and Utah certifying as of a recent date
      the good standing of Parent in New York and Utah;

            (l) certificates executed by the Secretary or Assistant Secretary of
      Seller and Parent certifying as to incumbency matters;

            (m) such further instruments of sale, transfer, conveyance,
      assignment or delivery covering the Acquired Assets, or any part thereof,
      as Buyer may reasonably require to assure the full and effective sale,
      transfer, conveyance, assignment or delivery to it of the Acquired Assets
      to be transferred pursuant to this Agreement;

      6.2 Closing Documents of Buyer. Seller and Parent shall have received or
are receiving on the date hereof, all of the following, each duly executed by
the parties thereto (other than Seller and Parent) and dated as of the date
hereof, in form and substance satisfactory to Seller and Parent:

            (a) Copies, certified by the Secretary or an Assistant Secretary of
      Buyer, of resolutions of its Board of Directors authorizing the execution,
      delivery and performance of this Agreement and the other Transaction
      Documents to which Buyer is a party and the consummation of the
      transactions contemplated hereby and thereby; and

            (b) the Transition Services Agreement between Buyer and Seller, in
      the form attached hereto as Exhibit C;

7. MISCELLANEOUS.

      7.1 Notices. All notices, requests, demands and other communications
hereunder shall be in writing and shall be deemed given (i) upon personal
delivery, (ii) three days after being mailed by certified or registered mail,
postage prepaid, return receipt requested, (iii) one business day after being
sent via a nationally recognized overnight courier service if overnight courier
service is requested from such service or (iv) upon receipt of electronic or
other confirmation of transmission if sent via facsimile and followed by
certified or registered mail, postage prepaid, return receipt requested, to the
parties, their successors in interest or their assignees at the following
addresses and telephone numbers, or at such other addresses or

                                       17
<PAGE>

telephone numbers as the parties may designate by written notice in accordance
with this Section 7.1:

      If to Buyer:               Saiful Kibria
                                 Bronson Nutritionals, LLC
                                 70 Commerce Drive
                                 Hauppauge, NY 11788
                                 Telephone:  (631) 842-3600
                                 Fax:  (631) 842-6008

      With a copy to:            Andrew D. Presberg, Esq.
                                 Andrew Presberg, P.C.
                                 100 Corporate Plaza
                                 Islandia, NY 11749
                                 Telephone:  (631) 232-4444
                                 Fax:  (631) 232-2603

      If to Seller or Parent:    Ross Blechman
                                 Chief Executive Officer and President
                                 Twin Laboratories Inc.
                                 150 Motor Parkway
                                 Hauppauge, NY 11788
                                 Telephone:  (631) 467-3140
                                 Fax:  (631) 630-3484

      With a copy to:            Howard A. Sobel, Esq.
                                 Latham & Watkins
                                 885 Third Avenue
                                 New York, NY  10022
                                 Telephone:  (212) 906-1322
                                 Fax:  (212) 751-4864

      7.2 Assignability and Parties in Interest. This Agreement and the rights,
interests or obligations hereunder may not be assigned by any of the parties
hereto without the written consent of the other party. This Agreement shall
inure to the benefit of and be binding upon Buyer, Seller and Parent and their
respective permitted successors and assigns. Nothing in this Agreement will
confer upon any Person not a party to this Agreement, or the legal
representatives of such Person any rights or remedies of any nature or kind
whatsoever under or by reason of this Agreement.

      7.3 Governing Law. This Agreement shall be governed by, and construed and
enforced in accordance with, the laws of the State of New York, without giving
effect to its conflicts of laws principles or rules which would require the
application of the law of any other jurisdiction.

      7.4 Venue. Any civil action or legal proceeding arising out of or relating
to this Agreement shall be brought in the courts of record of the State of New
York in Suffolk County

                                       18
<PAGE>

or the United States District Court, Eastern District of New York. Each party
consents to the jurisdiction of such court in any such civil action or legal
proceeding and waives any objection to the laying of venue of any such civil
action or legal proceeding in such court. Service of any court paper may be
effected on such party by mail, as provided in this Agreement, or in such other
manner as may be provided under applicable laws, rules of procedure or local
rules.

      7.5 Counterparts. Facsimile transmission of any signed original document
or retransmission of any signed facsimile transmission will be deemed the same
as delivery of an original. At the request of any party, the parties will
confirm facsimile transmission by signing a duplicate original document. This
Agreement may be executed in counterparts, each of which shall be deemed an
original, but all of which shall constitute but one and the same instrument.

      7.6 Complete Agreement. This Agreement, the exhibits and schedules hereto
(which are incorporated herein by this reference) and the other Transaction
Documents contain the entire agreement between the parties hereto with respect
to the transactions contemplated herein and therein and supersede all previous
oral and written and all contemporaneous oral negotiations, commitments, and
understandings.

      7.7 Modifications, Amendments and Waivers.

            (a) At any time prior to the termination of this Agreement, Seller
and Parent, on the one hand, and Buyer on the other may, (i) waive any
inaccuracies in the representations and warranties of Buyer, on the one hand,
and Seller and Parent on the other contained in this Agreement or in any other
Transaction Document; and (ii) waive compliance by Buyer, on the one hand, and
Seller and Parent on the other with any of the covenants or agreements contained
in this Agreement.

            (b) No waiver of any of the provisions of this Agreement will be
considered, or will constitute, a waiver of any of the rights or remedies, at
law or equity, of the party entitled to the benefit of such provisions unless
made in writing and executed by the party entitled to the benefit of such
provision. The waiver by any party of any right under this Agreement or to a
remedy for the breach of any of the provisions herein shall not operate nor be
construed by the breaching party as a waiver of the non-breaching party's
remedies with respect to any other or continuing or subsequent breach.

      7.8 Headings; References. The headings contained in this Agreement and the
other Transaction Documents are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement. References herein to
Articles, Sections, Schedules and Exhibits refer to the referenced Articles,
Sections, Schedules or Exhibits hereof unless otherwise specified.

      7.9 Rules of Construction.

            (a) Unless the context otherwise requires: (a) "or" is not
exclusive; (b) words in the singular include the plural, and words in the plural
include the singular; (c) "herein", "hereof", "hereto" and other words of
similar import refer to this Agreement as a whole and not to any particular
Article, Section or other subdivision; and (d) any gender used in this Agreement
shall be deemed to include the neuter, masculine and feminine genders.

                                       19
<PAGE>

            (b) The disclosure of any matter in any Schedule to this Agreement
shall be deemed to be a disclosure for all purposes of this Agreement to which
such matter would reasonably be expected to be pertinent, but shall expressly
not be deemed to constitute an admission by any party hereto, or to otherwise
imply, that any such matter is material for the purposes of this Agreement. In
addition, matters reflected on the Schedules are not necessarily limited to
matters required by this Agreement to be reflected thereon and the inclusion of
such matters shall not be deemed an admission that such matters (or additional
matters) were required to be reflected in the applicable Schedules.

      7.10 Severability. If any provision of this Agreement is invalid, illegal,
or unenforceable in any jurisdiction, as to that jurisdiction, such provision
shall be deemed amended to the extent required to make it valid, legal and
enforceable, and to the extent that the rights or obligations of the parties
under this Agreement will not be materially and adversely effected thereby, such
amended provision and the remaining provisions of this Agreement will remain in
full force and effect in such jurisdiction and shall not render that or any
other provision of this Agreement invalid, illegal, or unenforceable in any
other jurisdiction.

      7.11 Investigation. Except as otherwise expressly provided in this
Agreement, all representations and warranties contained herein which are made to
the knowledge of a party shall require that such party make reasonable
investigation and inquiry with respect thereto to ascertain the correctness and
validity thereof.

      7.12 Expenses of Transactions. Except as otherwise expressly provided in
this Agreement, all fees, costs and expenses incurred by Buyer in connection
with the transactions contemplated by this Agreement shall be borne by Buyer,
and all fees, costs, and expenses incurred by Seller or Parent in connection
with the transactions contemplated by this Agreement shall be borne by Seller
and Parent jointly and severally.

      7.13 Enforcement of the Agreement. Seller, Parent and Buyer acknowledge
that irreparable damage would occur to Buyer if, after the Closing, the
obligations of Seller and Parent under this Agreement with respect to the
Acquired Assets were not performed in accordance with their specific terms or
were otherwise breached. Buyer will be entitled to an injunction or injunctions
to prevent breaches of this Agreement by Seller or Parent and to enforce
specifically the terms and provisions hereto, this being in addition to any
other remedy to which Buyer is entitled at law or in equity.

                                       20
<PAGE>

      IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement
as of the date first above written.

                                    BRONSON NUTRITIONALS, LLC

                                    "BUYER"

                                    By:
                                       ---------------------------------------
                                       Name:  Saiful Kibria
                                       Title: Member

                                    KABCO PHARMACEUTICALS, INC.

                                    "BUYER"

                                    By:
                                       ---------------------------------------
                                       Name:
                                       Title:

                                    BRONSON LABORATORIES, INC.

                                    "SELLER"

                                    By:
                                       ---------------------------------------
                                       Name:
                                       Title:

                                    TWIN LABORATORIES INC.

                                    "PARENT"

                                    By:
                                       ---------------------------------------
                                       Name:
                                       Title:

                                       21
<PAGE>

                                 SCHEDULE 1.1(A)

                                 ACQUIRED ASSETS

1.    All customer lists and records of Bronson Laboratories, Inc., including
      wholesale and retail customers.

2.    List of the suppliers, vendors and contact personnel at the suppliers and
      vendors identified on Schedule 2.14(a)(ii).

3.    Goodwill in the Business, assignable licenses, the name "Bronson
      Laboratories" and telephone numbers used in the Business.

4.    All fixed assets owned by the Seller and used exclusively in connection
      with the business operations of the Seller as identified on Exhibit A to
      the Agreement.

5.    All computer files, records, software, hardware and data owned by the
      Seller and used exclusively in Seller's business operations, wherever
      located (including but not limited to the Sigma computer system, server,
      software and data), as set forth on Exhibit A.

6.    Summary information relating to the employees listed on Schedule 4.3 to
      the extent permitted by applicable law, rule or regulation.

7.    All catalogs, order forms, artwork and computer files utilized for the
      production of the Bronson catalog and mailings, including, but not limited
      to, all graphic materials in all forms (hard copy, software, discs, etc.),
      photos, images (in all forms), copy, transparencies for any and all
      Bronson projects - past, current and in process; stock art disc library;
      printed library of previous promotions; all graphic work up records and
      files.

8.    All intellectual property rights, including trademarks, owned by Seller
      and utilized in the Business, as well as product formulations for the
      Bronson Products and the rights to the Bronson Online website.

9.    Bronson branded shipping and packaging material inventory.

<PAGE>

                                 SCHEDULE 1.1(B)

                                 EXCLUDED ASSETS

1.    Telephone Equipment and other equipment owned by Parent and located at
      American Fork, Utah; and

2.    All accounts receivable generated from products shipped (including any
      intercompany receivables) through the date that is one day immediately
      preceding the date of the Closing.

<PAGE>

                                    EXHIBIT A

                              FORM OF BILL OF SALE

                                  BILL OF SALE

      1. DEFINITIONS.

      All capitalized terms not defined herein shall have the meanings ascribed
to them in that certain Asset Purchase Agreement (the "AGREEMENT") of even date
herewith, by and among Bronson Nutritionals, LLC, a New York limited liability
company ("BUYER"), Kabco Pharmaceuticals, Inc., a New York corporation
("KABCO"), Bronson Laboratories, Inc., a Delaware corporation ("SELLER") and
Twin Laboratories Inc., a Utah corporation and parent corporation of the Seller
("PARENT").

      2. BILL OF SALE.

      Pursuant to the Agreement and for good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, Seller hereby grants,
sells, conveys, transfers, assigns and delivers to Buyer, free and clear of all
liens and encumbrances, all of its right, title and interest in and to all of
the assets set forth on the Acquired Assets Schedule attached hereto as Schedule
A, to have and to hold the same unto Buyer and the heirs, successors and assigns
of the Buyer forever. Notwithstanding the foregoing, Seller does not hereby
sell, assign, transfer or deliver to Buyer any of Seller's right, title and
interest in and to any of the assets set forth on the Excluded Assets Schedule
attached hereto as Schedule B. The representations and warranties of Seller and
Parent contained in the Agreement are incorporated as part of this Bill of Sale,
subject to all of the provisions of the Agreement, including, but not limited
to, Section 5.6.

      Seller hereby constitutes and appoints Buyer, its successors and assigns,
as Seller's true and lawful attorney with full power of substitution in Seller's
name and stead, on behalf of and for the benefit of Buyer, its successors and
assigns, solely to demand and receive any and all of the Acquired Assets
transferred hereunder and to give receipts and releases for and in respect of
the same, and any part thereof, and from time to time to institute and prosecute
in Seller's name, or otherwise, for the benefit of Buyer, its successors and
assigns, any and all proceedings at law, in equity or otherwise, which Buyer,
its successors or assigns, may deem proper for the collection or reduction to
possession of any of the Acquired Assets transferred hereunder or for the
collection and enforcement of any claim or right of any kind hereby sold,
conveyed, transferred, assigned or delivered, or intended so to be, and to do
all other acts and things in relation to the Acquired Assets that Buyer, its
successors or assigns, shall deem desirable. Seller hereby declares that the
foregoing powers are coupled with an interest and are and shall be irrevocable
by Seller in any manner or for any reason whatsoever.

                                       22
<PAGE>

      This instrument shall be governed by and construed in accordance with the
laws of the State of New York without regard to its conflicts-of-laws
principles.

<PAGE>

      IN WITNESS WHEREOF, Seller has executed and delivered this Bill of Sale as
of the 17th day of January, 2003.

                                    BRONSON LABORATORIES, INC.,
                                    a Delaware corporation

                                    By:
                                       ------------------------------------
                                    Name:
                                         ----------------------------------
                                    Title:
                                          ---------------------------------

<PAGE>

                                   SCHEDULE A

                                 ACQUIRED ASSETS

<PAGE>

                                   SCHEDULE B

                                 EXCLUDED ASSETS

<PAGE>

                                    EXHIBIT B

                         FORM OF INVENTORY BILL OF SALE

      1. BILL OF SALE.

            1.1 For aggregate consideration of $3,000,000 (the "INVENTORY
PURCHASE Price"), subject to adjustment as described in Paragraph 1.2 below,
Bronson Laboratories, Inc. ("SELLER") hereby grants, sells, conveys, transfers,
assigns and delivers to Bronson Nutritionals, LLC ("BUYER"), free and clear of
all liens and encumbrances, all of its right, title and interest in and to all
of the inventory, raw materials, work in process and finished goods listed on
the Bronson Laboratories Inventory Summary, attached hereto as Schedule A (the
"INVENTORY"), to have and to hold the same unto Buyer and the heirs, successors
and assigns of Buyer forever.

            1.2 The Inventory Purchase Price shall be adjusted so that, to the
extent that the value of the Inventory, as determined on a cost basis as agreed
to by the parties (the "BOOK VALUE") on the date hereof, is greater than
$2,000,000, the Inventory Purchase Price shall be increased, on a dollar for
dollar basis, by an amount equal to the difference between the Book Value and
$2,000,000 (the "PURCHASE PRICE INCREASE"), such Purchase Price Increase shall
in no event exceed $500,000. Buyer shall have 90 days from the Closing Date to
pay to Seller, by wire transfer of immediately available funds, the amount, if
any, of the Purchase Price Increase. To the extent that the Book Value on the
date hereof is less than $2,000,000, the Inventory Purchase Price shall be
reduced, on a dollar for dollar basis, by an amount equal to the difference
between $2,000,000 and the Book Value (the "PURCHASE PRICE REDUCTION"). Seller
shall promptly reimburse to Buyer, by wire transfer of immediately available
funds, the amount, if any, of the Purchase Price Reduction. The parties agree
that, within fifteen business days of the Closing Date (the "VALUATION PERIOD"),
they shall determine the Book Value in accordance with procedures to be agreed
upon by the parties. To the extent that the parties are unable to agree upon the
Book Value during the Valuation Period, an independent accounting firm selected
by, and mutually acceptable to, and whose fees and expenses shall be shared
equally by, Seller and Buyer shall determine the Book Value. Seller and Buyer
shall be bound by the Book Value as determined by the independent accounting
firm. The independent accounting firm shall make the determination of the Book
Value within thirty Business Days of the selection of the independent accounting
firm.

            1.3 Seller hereby constitutes and appoints Buyer, its successors and
assigns, as Seller's true and lawful attorney with full power of substitution in
Seller's name and stead, on behalf of and for the benefit of Buyer, its
successors and assigns, solely to demand and receive any and all of the
Inventory transferred hereunder and to give receipts and releases for and in
respect of the same, and any part thereof, and from time to time to institute
and prosecute in Seller's name, or otherwise, for the benefit of Buyer, its
successors and assigns, any and all proceedings at law, in equity or otherwise,
which Buyer, its successors or assigns, may deem proper for the collection or
reduction to possession of any of the Inventory transferred hereunder or for the
collection and enforcement of any claim or right of any kind hereby sold,
conveyed, transferred, assigned or delivered, or intended so to be, and to do
all other acts and things in relation to the Inventory that Buyer, its
successors or assigns, shall deem desirable. Seller hereby declares that the
foregoing powers are coupled with an interest and are and shall be irrevocable
by Seller in any manner or for any reason whatsoever.

                                       23
<PAGE>

      2. REPRESENTATIONS AND WARRANTIES OF SELLER.

            Seller hereby represents and warrants to Buyer as follows:

            2.1 Inventory. Seller has and will transfer good and legal title to
the Inventory, and Buyer will acquire good and legal title to the Inventory,
free and clear of any and all liens, claims, security interests and other
encumbrances of any kind or nature whatsoever.

            2.2 Condition of Inventory. The Inventory is in good and
merchantable condition and is suitable and usable or saleable in the ordinary
course of the Business for the purposes intended, net of reserves set forth on
(or consistent with the amounts set forth on) the Seller and/or Parent's books
or records. The Inventory that consists of finished products does not have an
expiration date that is less than six months from the date of this Bill of Sale.

            2.3 Storage of Inventory. Since receipt by Seller of the Inventory,
Seller has stored the Inventory in accordance with generally accepted industry
standards and has not altered, modified or otherwise tampered with the
Inventory.

            2.4 Nature of Inventory. The Inventory is of the description thereof
in the Bronson Laboratories Inventory Summary attached hereto.

      3. COVENANTS.

            3.1 Supplier's Warranties. Seller hereby transfers, conveys and
assigns all representations and warranties relating to the Inventory made by
each supplier of the Inventory in favor of Seller to Buyer, to the extent
transferable by Seller.

            3.2 Further Assurances. Seller agrees that it will from time to time
on demand execute any further instruments which Buyer may deem necessary,
desirable or proper to effect the complete transfer of the Inventory to Buyer or
better to evidence the right, title and interest of Buyer in the Inventory.

            3.3 EXCEPT AS EXPRESSLY SET FORTH HEREIN, SELLER MAKES NO
WARRANTIES, EXPRESS, IMPLIED (EITHER IN FACT OR BY OPERATION OF LAW), OR ARISING
BY PERFORMANCE, COURSE OF DEALING, CUSTOM OR USAGE, AS TO ANY MATTER WHATSOEVER,
INCLUDING WITHOUT LIMITATION THE IMPLIED WARRANTIES OF MERCHANTABILITY AND
FITNESS FOR A PARTICULAR PURPOSE. ANY OTHER REPRESENTATIONS OR WARRANTIES MADE
BY ANY PERSON, INCLUDING EMPLOYEES OR REPRESENTATIVES OF SELLER, SHALL BE
DISREGARDED BY BUYER AND SHALL NOT BE BINDING UPON SELLER.

      4. RECEIPT.

      Seller acknowledges receipt of $3,000,000 from the Buyer as payment in
full for the Inventory.

      5. GOVERNING LAW.

                                       24
<PAGE>

      This instrument shall be governed by and construed in accordance with the
laws of the State of New York without regard to its conflicts-of-laws
principles.

<PAGE>

      IN WITNESS WHEREOF, Seller has executed and delivered this Bill of Sale as
of the 17th day of January, 2003.

                                    BRONSON LABORATORIES, INC.,
                                    a Delaware corporation

                                    By:
                                       ---------------------------------------
                                    Name:
                                         -------------------------------------
                                    Title:
                                          ------------------------------------

<PAGE>

                                   SCHEDULE A

                     BRONSON LABORATORIES INVENTORY SUMMARY

<PAGE>

                                    EXHIBIT C

                      FORM OF TRANSITION SERVICES AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]